T-cell receptor on CD4+ helper T cell specific for HIV-1 Env, Gag, and Pol peptides (HIV-specific CD4+ TCR)

T-cell receptors (TCRs) on CD4+ helper T cells specific for HIV-1 Env, Gag, and Pol-derived peptides are essential mediators of the adaptive immune response against Human Immunodeficiency Virus (HIV) (Wikipedia, 2024). These receptors recognize specific viral epitopes presented by Major Histocompatibility Complex class II (MHC-II) molecules on antigen-presenting cells or infected cells (NIH, 2021; NIH, 2025). Upon recognition, these CD4+ T cells provide critical helper signals to CD8+ cytotoxic T cells and B cells, facilitating a coordinated immune attack and promoting long-term memory (NIH, 2017; Wikipedia, 2024). In many individuals with HIV, these specific T-cell populations are preferentially infected, depleted, or rendered dysfunctional through exhaustion, contributing to the failure of natural viral control (OUP, 2021; Ragon Institute, 2012). Therapeutic interventions aim to harness these TCRs through therapeutic vaccines, such as the HTI immunogen, or through adoptive cell therapies like TCR-engineered T cells (TCR-T) to restore antiviral immunity and target the latent viral reservoir (OUP, 2021; NIH, 2025; PR Newswire, 2026). Monitoring the breadth and diversity of these TCR responses serves as a key biomarker for evaluating the efficacy of HIV immunotherapies and the state of the latent viral reservoir (NIH, 2021; NIH, 2025).

Other names

HIV-specific CD4+ T-cell receptorHIV-1 antigen-specific TCRCD4+ TCR (Env/Gag/Pol)HIV-specific helper T-cell receptor

Recognition of MHC-II-presented viral peptides (Env, Gag, Pol) leading to T-cell activation, cytokine release, and enhancement of antiviral immune responses.